Side-by-side comparison of AI visibility scores, market position, and capabilities
Los Angeles textile-to-textile molecular recycler; cycora® regenerated polyester with Inditex €70M+ supply deal and Goldwin FW2025 partnership; $44M raised with 250,000 T-shirt/day facility by 2026 competing with Evrnu for circular fashion materials.
Ambercycle is a Los Angeles, California-based materials science company — backed with approximately $44 million in total funding including investments from Goldwin Play Earth Fund, Shinkong Synthetic Fibers, and others — providing the global apparel and textile industry with cycora®, the world's first commercial-scale textile-to-textile regenerated polyester produced through the company's proprietary Ambercycling™ molecular regeneration technology that transforms post-consumer textile waste into virgin-grade polyester fiber. Key brand partnerships include Inditex/Zara (€70+ million three-year supply agreement), Athleta, REI, Reformation, and GANNI, with manufacturing through MAS Holdings. Ambercycle plans to open a commercial-scale facility capable of processing the equivalent of 250,000 T-shirts per day by 2026. cycora® won Time Magazine's Best Inventions of 2024 recognition. Founded 2015 by UC Davis alumni Shay Sethi (CEO) and Moby Ahmed.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.